PMID- 37730486
OWN - NLM
STAT- MEDLINE
DCOM- 20231117
LR  - 20240319
IS  - 1879-3061 (Electronic)
IS  - 1043-2760 (Linking)
VI  - 34
IP  - 12
DP  - 2023 Dec
TI  - Road map for personalized exercise medicine in T2DM.
PG  - 789-798
LID - S1043-2760(23)00166-2 [pii]
LID - 10.1016/j.tem.2023.08.013 [doi]
AB  - The number of patients with type 2 diabetes mellitus (T2DM) is rising at an 
      alarming rate. Regular physical activity and exercise are cornerstones in the 
      therapy of T2DM. While a one-size-fits-all approach fails to account for many 
      between-subject differences, the use of personalized exercise medicine has the 
      potential of optimizing health outcomes. Here, a road map for personalized 
      exercise therapy targeted at patients with T2DM is presented. It considers 
      secondary complications, glucose management, response heterogeneity, and other 
      relevant factors that might influence the effectiveness of exercise as medicine, 
      taking exercise-medication-diet interactions, as well as feasibility and 
      acceptance into account. Furthermore, the potential of artificial intelligence 
      and machine learning-based applications in assisting sports therapists to find 
      appropriate exercise programs is outlined.
CI  - Copyright (c) 2023 Elsevier Ltd. All rights reserved.
FAU - Brinkmann, Christian
AU  - Brinkmann C
AD  - Institute of Cardiovascular Research and Sport Medicine, Department of Preventive 
      and Rehabilitative Sport Medicine, German Sport University Cologne, Cologne, 
      Germany; Department of Fitness & Health, IST University of Applied Sciences, 
      Dusseldorf, Germany. Electronic address: ch.brinkmann@gmx.net.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20230918
PL  - United States
TA  - Trends Endocrinol Metab
JT  - Trends in endocrinology and metabolism: TEM
JID - 9001516
SB  - IM
MH  - Humans
MH  - *Diabetes Mellitus, Type 2/therapy
MH  - Artificial Intelligence
MH  - Exercise
MH  - Exercise Therapy
MH  - Diet
OTO - NOTNLM
OT  - artificial intelligence
OT  - individualized training
OT  - personalized exercise medicine
OT  - training planning
OT  - type 2 diabetes mellitus
COIS- Declaration of interests C.B. is a member of the Abbott advisory board and has 
      received honoraria from Novo Nordisk. The companies had no role in preparation of 
      the manuscript or decision to publish.
EDAT- 2023/09/21 00:42
MHDA- 2023/11/17 15:25
CRDT- 2023/09/20 21:54
PHST- 2023/07/09 00:00 [received]
PHST- 2023/08/20 00:00 [revised]
PHST- 2023/08/21 00:00 [accepted]
PHST- 2023/11/17 15:25 [medline]
PHST- 2023/09/21 00:42 [pubmed]
PHST- 2023/09/20 21:54 [entrez]
AID - S1043-2760(23)00166-2 [pii]
AID - 10.1016/j.tem.2023.08.013 [doi]
PST - ppublish
SO  - Trends Endocrinol Metab. 2023 Dec;34(12):789-798. doi: 10.1016/j.tem.2023.08.013. 
      Epub 2023 Sep 18.